UCB to restrict 340B discounts to hospitals using community pharmacies

Beginning Dec. 13, global drug company UCB will stop providing 340B discounts to hospitals for drugs dispensed at community-based pharmacies.

UCB is now the ninth drug company to restrict 340B pricing for community pharmacies, according to a Nov. 23 news release from 340B Health, an association representing more than 1,400 public and private nonprofit hospitals and health systems participating in the federal drug pricing program, which requires drugmakers to sell their products at a discount to providers who serve low-income communities.